Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F88MG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,381
Award facts
- Contract value 100% obligated
- $15,381.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,381.32 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on January 14, 2026, with completion expected by January 15, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems including the Department of Defense and the Defense Health Agency.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains. The Ozempic delivery represents one of numerous task orders issued under this strategic pharmaceutical support agreement that serves military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F88MG?
SPE2DR26F88MG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F88MG worth?
The government has obligated $15,381 on SPE2DR26F88MG.
Is contract SPE2DR26F88MG an order under another contract?
Yes. SPE2DR26F88MG is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88MG competed?
The extent of competition for SPE2DR26F88MG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award